Paper39005483
CURE: A deep learning framework pre-trained on large-scale patient data for treatment effect estimation.
Liu R and 2 others. Patterns (N Y), 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. CURE: A deep learning framework pre-trained on large-scale patient data for treatment effect estimation. Papers, record 39005483. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39005483
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CURE: A deep learning framework pre-trained on large-scale patient data for treatment effect estimation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 GM141279 | NIGMS NIH HHS | United States | R01GM141279 | PubMed |
Source NIH RePORTER
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32346050 | BEHRT: Transformer for Electronic Health Records. | Sci Rep | 2020 | https://conductscience.org/library/papers/32346050 | PubMed |
| 2 | 34758252 | Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34758252 | PubMed |
| 3 | 26994063 | Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available. | Am J Epidemiol | 2016 | https://conductscience.org/library/papers/26994063 | PubMed |
| 4 | 34017034 | Med-BERT: pretrained contextualized embeddings on large-scale structured electronic health records for disease prediction. | NPJ Digit Med | 2021 | https://conductscience.org/library/papers/34017034 | PubMed |
| 5 | 23297653 | Causal inference in public health. | Annu Rev Public Health | 2013 | https://conductscience.org/library/papers/23297653 | PubMed |
| 6 | 32160801 | Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease. | Circulation | 2020 | https://conductscience.org/library/papers/32160801 | PubMed |
| 7 | 35603127 | A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data. | Nat Mach Intell | 2021 | https://conductscience.org/library/papers/35603127 | PubMed |
| 8 | 30770453 | Metalearners for estimating heterogeneous treatment effects using machine learning. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/30770453 | PubMed |
| 9 | 10738049 | Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. | N Engl J Med | 2000 | https://conductscience.org/library/papers/10738049 | PubMed |
| 10 | 39005483 | CURE: A deep learning framework pre-trained on large-scale patient data for treatment effect estimation. | Patterns (N Y) | 2024 | https://conductscience.org/library/papers/39005483 | PubMed |
| 11 | 25390318 | Randomised controlled trials for Ebola: practical and ethical issues. | Lancet | 2014 | https://conductscience.org/library/papers/25390318 | PubMed |
| 12 | 15026432 | A definition of causal effect for epidemiological research. | J Epidemiol Community Health | 2004 | https://conductscience.org/library/papers/15026432 | PubMed |
| 13 | 21870978 | Apixaban versus warfarin in patients with atrial fibrillation. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21870978 | PubMed |
| 14 | 9468688 | Understanding controlled trials. Why are randomised controlled trials important? | BMJ | 1998 | https://conductscience.org/library/papers/9468688 | PubMed |
| 15 | 31750899 | Ticagrelor monotherapy versus aspirin in patients undergoing multiple arterial or single arterial coronary artery bypass grafting: insights from the TiCAB trial. | Eur J Cardiothorac Surg | 2020 | https://conductscience.org/library/papers/31750899 | PubMed |
| 16 | 29132880 | Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. | Lancet | 2018 | https://conductscience.org/library/papers/29132880 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39760722 | Artificial intelligence and stroke imaging. | Curr Opin Neurol | 2025 | https://conductscience.org/library/papers/39760722 | PubMed |
| 39060569 | AI and RCTs. | Br Dent J | 2024 | https://conductscience.org/library/papers/39060569 | PubMed |
| 39005493 | Large pre-trained models for treatment effect estimation: Are we there yet? | Patterns (N Y) | 2024 | https://conductscience.org/library/papers/39005493 | PubMed |
| 39005483 | CURE: A deep learning framework pre-trained on large-scale patient data for treatment effect estimation. | Patterns (N Y) | 2024 | https://conductscience.org/library/papers/39005483 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39005483
GET https://conductscience.org/api/papers/v1/39005483/authors